--- title: 'Manufacturing Daily Summary: What Happened on October 6, 2026' headline: ESTEVE adds $17.5 million to its Illinois CDMO expansion description: The latest investment brings announced spending at the Morton Grove site to $33 million. url: https://thebench.bio/news/manufacturing/2026-10-06 topic: manufacturing date: '2026-10-06' covers: - '2026-10-06' date_published: '2026-10-06T12:03:58Z' date_modified: '2026-10-06T18:50:52Z' sources: 2 publisher: The Bench (thebench.bio) --- # Manufacturing Daily Summary: What Happened on October 6, 2026 **ESTEVE adds $17.5 million to its Illinois CDMO expansion** The latest investment brings announced spending at the Morton Grove site to $33 million. ## Today in brief ESTEVE CDMO will add two 500-gallon reactors and upgrade its Morton Grove site, bringing announced investment there to $33 million. [1] Merck opened a BioReliance facility in Germany for European biologics development and testing. [2] ## ESTEVE expands Morton Grove site ESTEVE CDMO is investing another $17.5 million in its Morton Grove, Illinois, site, bringing announced investment there to $33 million. [1] The expansion includes two 500-gallon reactors, stronger containment in early-development labs and a warehouse renovation. [1] ## The day in numbers - **$33 million**: Total announced investment in ESTEVE CDMO’s Morton Grove site, including the additional $17.5 million. [1] - **2 × 500 gallons**: Capacity of the two reactors planned for ESTEVE’s Morton Grove facility. [1] ## Sources 1. [ESTEVE CDMO adds $17.5m to Illinois expansion](), Pharmafile, 2026-10-06 2. [Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe](), Labiotech, 2026-10-06 --- The Bench wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: